Apex Healthcare is an API manufacturer based in India. It holds 10 active US drug master files across a filed portfolio of 9 molecules. Its GMP standing is certified by CDSCO (India) and US FDA. Its most recent recorded inspection, by US FDA, closed on 15 June 2023 as VAI. Customs aggregates show $8.1M of exports covering 305 molecules to 46 destinations in 2025.
NAI means no action indicated, VAI means voluntary action indicated, and OAI means official action indicated.
| Site | FDA FEI |
|---|---|
| Ankleshwar, India | 3006509185 |
| bharuch 393 002, India | Not on file |
| Bharuch, India | Not on file |
| Molecule | Regulators | Docs |
|---|---|---|
| Lidocaine | US FDA | 2 |
| Acyclovir | US FDA | 1 |
| Benzocaine | US FDA | 1 |
| Bisacodyl | US FDA | 1 |
| Bupivacaine | US FDA | 1 |
| Meloxicam | US FDA | 1 |
| Piroxicam | US FDA | 1 |
| Prilocaine | US FDA | 1 |
| Ropivacaine | US FDA | 1 |
Also appears on these molecule pages
| Regulator | Filings | GMP certificates |
|---|---|---|
| MINSA (CR) | 2 | None |
| CDSCO (India) | None | 3 |
| US FDA | None | 1 |
| Year | Revenue | Exports | Destinations |
|---|---|---|---|
| 2026 YTD | Not reported | $931K | 20 |
| 2025 | Not reported | $8.1M | 46 |
| 2024 | Not reported | $6.2M | 41 |
| 2023 | Not reported | $4.5M | 33 |
Export figures are customs aggregates. We do not publish the identity of any buyer.
Answered from this company's own record. Where a register holds nothing, the question is not asked rather than answered with a zero. How we count our figures.
Choose your molecules and target markets. Apex Healthcare comes back tiered against every other supplier able to file there.
Start for freeRanked by shared active ingredients where we have them, otherwise by country and comparable credentials.